GL1X · GenesisL1 explorer

Ligand · 7OA

7OA · (3s,3ar,5r,7as,8s)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate

7OA, (3s,3ar,5r,7as,8s)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate (C33 H40 F2 N4 O7 S2, 706.8…

Component
7OA
Formula
C33 H40 F2 N4 O7 S2
Class
ligand
Structures
6
PDB entries
6

Binding sites

7OA in 6 structures; the first of them:

  • 5TYS · X-ray crystal structure of wild type HIV-1 protease in complex with grl-142 · 7OA A400 · binds LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32, ILE47 and 15 more
  • 6BZ2 · Crystal structure of wild-type HIV-1 protease with a novel HIV-1 inhibitor grl-14213A of… · 7OA B201 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32 and 17 more
  • 6MKL · X-ray crystal structure of darunavir-resistant-P51 HIV-1 protease in complex with grl-142 · 7OA A400 · binds ARG8, ASP25, GLY27, ALA28, ASP29, ASP30, ILE32, GLY48 and 17 more
  • 6OGR · X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with… · 7OA A101 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, ILE32 and 4 more
  • 6PRF · HIV-1 protease multiple drug resistant clinical isolate mutant PR20 with grl-14213A · 7OA B101 · binds LEU23, ASP25, GLY27, ALA28, ASP29, ASN30, ILE32, VAL47 and 15 more
  • 7MYY · Crystal structure of HIV-1 PRS17 with grl-142 · 7OA A101 · binds LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, ILE47, VAL48 and 16 more

Residues it binds most

ASP 6, GLY 6, ILE 6, ALA 6, VAL 5, LEU 6, ARG 6, PRO 5, ASN 1, SER 1 (residue and the binding sites it lines).

Found with

  • CL · Chloride ion
  • NA · Sodium ion
  • Y1 · Yttrium ion
  • ACT · Acetate ion
  • EDO · 1,2-ethanediol
  • GOL · Glycerol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.